Shradha Bhatnagar*
This review article explores the crucial elements of medication optimization for two common cardiovascular diseases: Atrial Fibrillation (AF) and Congestive Heart Failure (CHF). AF, characterized by irregular heartbeats, significantly increases the risk of heart failure and stroke. Effective anticoagulation medication is essential for reducing the risk of stroke, alongside rate control and rhythm control measures. The choice of therapy should be tailored to individual patient characteristics. CHF, a complex condition stemming from compromised heart function, is managed with guideline-directed pharmacological therapy, including ACE inhibitors, beta-blockers and diuretics. Recent advancements like Sodium-Glucose Cotransporter 2 (SGLT-2) inhibitors and Angiotensin Receptor Blockers (ARBs) have shown promise in improving patient outcomes.
Published Date: 2025-02-11; Received Date: 2024-03-15
